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Many physiological targets have been suggested for
polyphosphoinositol lipids, but two out of the three
monophosphorylated PIPs appeared to be no more
than metabolic precursors. Recent work has shown
that they also have distinct binding proteins and
functions. 
The canonical phosphoinositide pathway involves the
sequential phosphorylation of the relatively rare
membrane phospholipid, phosphatidylinositol. To date,
seven different ‘flavours’ of polyphosphoinositol lipids
have been discovered in mammalian cells, based on
the ability of a battery of specific kinases and phos-
phatases to regulate the phosphorylation of the D3, D4
and D5 positions on the inositol head-group (Figure 1).
As well as being hydrolysed to produce key second
messenger molecules, the intact polyphosphoinositol
lipids have been shown to be important regulators of a
number of cellular events [1]. The emerging complex-
ity of the functions of phosphatidylinositol lipids has
resulted in direct roles being attributed to all three
‘flavours’ of phosphatidylinositol bisphosphate (PIP2)
and to phosphatidylinositol trisphosphate (PIP3) in
processes such as vesicle trafficking, nuclear function
and cytoskeletal rearrangement [2–5]. 
Previously considered as intermediates in the
synthesis of PIP2, the monophosphorylated PIP species
— PI(3)P, PI(4)P and PI(5)P (Figure 1) — have also been
suspected to be important regulatory molecules in their
own right. It is well known that PI(3)P has a function in
intracellular vesicle trafficking [5]. This was originally
demonstrated in yeast, where genetic studies using
Saccharomyces cerevisiae led to the identification of
PI(3)P as an important mediator of membrane transport
from the Golgi complex to endosomes. 
Studies of homologs of the proteins identified from
genetic mutations in yeast uncovered a number of
effector molecules in mammalian cells that directly bind
to PI(3)P. One of these, the human early endosome
autoantigen 1 (EEA1) protein, is essential for the endo-
some fusion process that depends on the small
GTPase Rab5 [6]. This interaction is thought to confer
directionality to the endocytic pathway, and is an
example of an emerging picture of D3 polyphospho-
inositol lipid-mediated events in trafficking processes
(Figure 2). Two recent papers [7,8] have now completed
the PIP set, by assigning physiological functions to
PI(4)P and PI(5)P.
Earlier yeast genetic screens suggested that PI(4)P
may also have a role in Golgi secretory function [5].
Analysis of lipids from temperature-sensitive secre-
tion mutants indicated that the Golgi pool of PI(4)P is
necessary to maintain a functional secretory pathway
[9]. Mutation of Pik1p, a trans-Golgi resident PI 4-
kinase, impaired synthesis of PI(4)P and led to inhi-
bition of vesicle trafficking from this organelle [9,10].
The mammalian ortholog of Pik1p is PI4KIIIβ, a type
III PI 4-kinase which is recruited to the Golgi by the
small GTPase ADP-ribosylation factor Arf1 [11]. Arf1-
mediated PI4KIIIβ activity was shown to be neces-
sary for the regulation of Golgi structure. But as Arf1
also recruited a PI(4)P 5-kinase to the Golgi, the sup-
position was made that the PI4KIIIβ-generated pool
of PI(4)P is converted directly to PI(4,5)P2, and that
this is the lipid that has downstream regulatory
effects [11]. 
Recent work on the involvement of PI(4,5)P2 in mem-
brane trafficking would support this view. Padrón and
co-workers [12] showed that PI(4,5)P2 production in
the plasma membrane is mediated by the PIP kinase
type Iβ isoform. Increases in the levels of PIP2 — not
PI(4)P – were found to affect the rates of constitutive
endocytosis in mammalian cells, associated with the
recruitment of the adaptor protein AP-2 to the plasma
membrane (Figure 2).
The new work by Wang et al. [7], however, suggests
that PI(4)P also has a primary function in the mam-
malian Golgi, and has answered some of the questions
about the role of this lipid in vesicle trafficking. The
identification of the type II PI 4-kinase PI4KIIα as an
Arf1-independent Golgi-resident protein allowed this
group to determine the effect of reducing its activity in
cells by RNA interference (RNAi). The results indicated
that the type II PI4KIIα, rather than a type III isoform, is
the major PI 4-kinase activity contributing to PI(4)P
synthesis in the Golgi. Significantly, RNAi of PI4KIIα
blocked membrane association of AP-1, required for
regulation of clathrin-coated vesicle trafficking from
the trans-Golgi network, whereas RNAi of other Golgi-
associated PI 4-kinases did not. 
Wang et al. [7] further showed that AP-1 binds specif-
ically to PI(4)P, that this binding is the determinant of
AP-1 recruitment to the Golgi in vivo, and that it is inde-
pendent of the subsequent generation of PI(4,5)P2
(Figure 2). Arf1 also mediates AP-1 complex recruitment
to the Golgi, and it has been postulated that a multi-
component docking mechanism could exist [4]. The
idea that a PI(4)P-rich membrane patch is attractive to
AP-1 and accessory proteins such as epsinR (Figure 2)
— also shown to specifically bind to this PIP [13] —
leads to speculation as to whether this lipid-mediated
complex assembly process is more common. An
example would involve the binding of the cytoskeletal
protein talin to PI(4)P [14], which may potentially play a
role in the association of focal adhesion components
such as talin and PIP kinase type Iγ [15].
PI(5)P, the third PIP to be identified in mammalian
cells — this lipid species is thought not to be present in
yeast — has also recently been the subject of functional
studies [8,16]. Evidence suggests that this lipid may
have an indirect effect on insulin signal transduction, as
overproduction of the PI(5)P 4-kinase β isoform, which
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would be expected to reduce PI(5)P levels (Figure 1),
abolishes activation of the downstream protein kinase
Akt/PKB. These authors suggest that PI(5)P may inhibit
a PIP3-specific 5-phosphatase, although it has not been
confirmed that reduction of PIP3 is directly due to loss
of cellular PI(5)P [16].
PI(5)P has also been shown to be present in the
nucleus, and its cellular concentration changes
markedly during the cell cycle [17]. The recently
reported discovery of a PI(5)P-binding protein by
Gozani et al. [8] has suggested that the nuclear pool of
this lipid is important in the response to DNA damage.
A novel binding motif on ING2 — product of a putative
tumour suppressor gene — was shown specifically to
bind PI(5)P in vivo, and experiments with over-
expressed PIP kinase type IIβ indicate that this binding
regulates ING2 association with chromatin. The sub-
sequent localised activation of ING2 led to acetylation
of the p53 tumour suppressor, known to be an apop-
totic response to DNA damaging agents (Figure 2).
In summary, the different cellular PIPs are now seen
to have focal roles in a variety of diverse cellular
pathways. Initial analyses in yeast provided the basis
for studies in mammalian cells, where a more complex
repertoire of lipid interactions is emerging. Moreover,
the discovery of effector molecules that associate with
target membranes, via specific lipid-binding domains,
suggests that membrane identity can be mediated by
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Figure 2. Phosphoinositol lipid-
mediated cellular processes. 
Red shapes represent PIPs — the
numbers denote species: 3, PI(3)P; 4,
PI(4)P; and 5, PI(5)P — associated with
various membrane and chromatin
structures; purple shapes represent
PI(4,5)P2. Boxes indicate proteins or
complexes with direct lipid binding
characteristics. PIP2 generated by PIP
kinase at the plasma membrane is
required for AP-2 recruitment and
clathrin-coated vesicle formation [12].
Binding of EEA1 to PI(3)P is required
for Rab5-mediated endosome fusion
[6]. PI4KIIα generated PI(4)P is required
for AP-1 complex recruitment to the
Golgi for vesicle trafficking [7] and
binding of ING2 to chromatin-associ-
ated PI(5)P mediates responses involv-
ing the p53 tumour suppressor [8].
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Figure 1. The synthesis and
interconversion reactions of the seven
different ‘flavours’ of phosphoinositide
lipid.
For clarity, only relevant kinases (italics)
that catalyse the addition of a phosphate
group (red circle) are shown. Double-
headed arrows indicate that kinases and
phosphatases operate on these sub-
strates; however, some reactions may
have been shown only in vitro, and with a
certain amount of enzyme promiscuity —
for example type I PIP kinase will also act
as a PI 5-kinase [1]. Large bold items rep-
resent PIP synthesis. The D3-5 positions
of the inositol ring have been indicated on
the phosphoinositol molecule. Classical
second messenger production from
PI(4,5)P2 has also been shown [1].
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compartmentalisation of specific polyphosphoinositol
lipids. Examples of such functions include stabilising
vesicle docking by the association of EEA1 with PI(3)P
in early endosome membranes via a FYVE finger RING
domain [4,6]; regulation of Golgi function by the asso-
ciation of the AP-1 complex with PI(4)P, possibly medi-
ated by the accessory protein epsinR via its ENTH
domain [13]; and induction of apoptotic pathways by
the association of ING2 with PI(5)P via a PHD finger
domain [8]. The ability of lipids to compartmentalise to
domains within biological membranes makes the iden-
tification of further binding partners and functions an
exciting prospect in cell signalling and regulation.
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